2010 Annual Meeting | NIH Sponsored Clinical Trials in Neurology: What's Going On? How to Participate? How Can We Do Better?
| 01:00 PM - 01:05 PM |
Introduction to NINDS Research
Story C. Landis, PhD |
|
| 01:05 PM - 01:20 PM |
Overview of NINDS Clinical Trials
Petra Kaufmann, MD, FAAN |
|
| 01:20 PM - 01:50 PM |
Combination Therapy for Patients with Multiple Sclerosis: The CombiRx Trial
Fred D. Lublin, MD, FAAN |
|
| 01:50 PM - 02:20 PM |
Interventions for Patients with Carotid Stenosis: Lessons learned from the CREST trial
Thomas G. Brott, MD, FAAN |
|
| 02:20 PM - 02:50 PM |
Approaches to Comparative Effectiveness Research
Deborah Hirtz, MD, FAAN |
|
| 02:50 PM - 03:00 PM |
Questions and Suggestions
Walter J. Koroshetz, MD, FAAN |
| Thomas G. Brott, MD, FAAN | Dr. Brott has nothing to disclose. |
| Deborah Hirtz, MD, FAAN | No disclosure on file |
| Walter J. Koroshetz, MD, FAAN | Dr. Koroshetz has nothing to disclose. |
| Fred D. Lublin, MD, FAAN | Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurogene. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medimmune/Viela Bio/Horizon. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Receptos/Celgene/BMS. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Labcorp. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neuralight. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Entelexo. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lublin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Lublin has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Lublin has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Lublin has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for Multiple entities. Dr. Lublin has stock in Avotres. Dr. Lublin has stock in Neuralight. The institution of Dr. Lublin has received research support from Brainstorm. The institution of Dr. Lublin has received research support from biogen. The institution of Dr. Lublin has received research support from NIH. |
| Petra Kaufmann, MD, FAAN | Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to AAN interests or activities. |
| Story C. Landis, PhD | No disclosure on file |